MSc in Drug Design

University of Kent, School of Biosciences

Program Description

MSc in Drug Design

University of Kent, School of Biosciences

The MSc in Drug Design is a new interdisciplinary programme providing both academic and industrial insight into the key disciplines of early stage drug discovery.

The MSc course focuses on providing advanced academic training on approaches used in drug design and is of strategic relevance for academic, biotech or larger pharmaceutical company drug discovery. The programme spans the discovery programme from target identification and validation through to the clinic. It includes practical training in aspect of drug discovery in terms of both biological and biophysical approaches to studying ligand-protein protein-protein interactions drug targets using state of the art analytical techniques.

There are a range of optional modules allowing you to tailor your programme to your own interests and potential future careers.

Course content

The MSc in Drug Design involves studying for 120 credits of taught modules, as indicated below. The taught component takes place during the Autumn and Spring terms, while a 60-credit research project take place over the Summer months. The assessment of the course will involve a mixture of practical classes, innovative continuous assessment to gain maximise transferable and professional skills, and examinations. In additional to traditional scientific laboratory reports, experience will be gained in a range of scientific writing styles relevant to future employment.

Expert Teaching

The programme is taught by staff from the Biosciences, Centre for Molecular Processing and Industrial scientists who all have experience of working with the Drug Industry (both large Pharma and Biotech).

Programme details:

Core modules

  • Advanced Drug Design
  • Practical and Applied Research Skills for Advanced Biotechnologists and Bioengineers (30 credits Autumn term)
  • Science at Work (30 credits - Autumn term)
  • Biotechnology and Public Affairs (non credit-bearing Autumn term)
  • Research Project (60 credits)

Optional modules

  • Translational medicine: from the laboratory to the clinic (15 credits)
  • Targeted cancer therapies (15 credits)
  • Advanced Molecular Processing for Biotechnologists and Bioengineers; (30 credits)
  • New Enterprise Startup (15 credits)


Assessment is by examination, coursework and dissertation.

The research project will be assessed by written dissertation, presenting a poster at the annual School research symposium, oral presentation and viva voce examination.

Admissions requirements and fees

Students must have, or expect to have, a Second Class honours degree or above in Biosciences-related subject. Applications will be considered throughout the year and places filled on a competitive basis on the strength of the applications received.

The fees for this master's course are as follows:

£5,100 Home/EU students £14,860 International students

Fees for part-time study are half of the full-time equivalent.

Please note that the School of Biosciences has a number of funding and scholarship opportunities for master's students. Please visit the funding and scholarships page to review eligibility criteria and the application procedure.

This school offers programs in:
  • English

Last updated February 1, 2016
Duration & Price
This course is Campus based
Start Date
Start date
Aug. 2017
Part time
Full time
Start date Aug. 2017
United Kingdom Canterbury, England
Application deadline Request Info
End date Request Info
Duration Request Info
Price Request Info